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Edited by Lukas HuberAbstract 4-Hydroxyhexenal (HHE) is known to aﬀect redox
balance during aging, included are vascular dysfunctions. To
better understand vascular abnormality through the molecular
alterations resulting from HHE accumulation in aging processes,
we set out to determine whether up-regulation of mitogen-
activated protein kinase (MAPK) by HHE is mediated through
nuclear factor kappa B (NF-jB) activation in endothelial cells.
HHE induced NF-jB activation by inhibitor of jB (IjB)
phosphorylation via the IjB kinase (IKK)/NF-jB inducing
kinase (NIK) pathway. HHE increased the activity of p38
MAPK and extracellular signal regulated kinase (ERK), but not
c-jun NH2-terminal kinase, indicating that p38 MAPK and ERK
are closely involved in HHE-induced NF-jB transactivation.
Pretreatment with ERK inhibitor PD98059, and p38 MAPK
inhibitor SB203580, attenuated the induction of p65 transloca-
tion, IjB phosphorylation, and NF-jB luciferase activity. These
ﬁndings strongly suggest that HHE induces NF-jB activation
through IKK/NIK pathway and/or p38 MAPK and ERK
activation associated with oxidative stress in endothelial cells.
 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: 4-Hydroxyhexenal; NF-jB; MAPK; IKK; NIK1. Introduction
Lipid peroxidation induced by reactive oxygen species
(ROS) is known to be involved in many processes that are
biologically damaged [1,2]. Termination of lipid peroxidation
occurs when two radical species react with each other to form a* Corresponding author. Fax: +82-51-518-2821.
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Abbreviations: HHE, 4-hydroxyhexenal; HNE, 4-hydroxynonenal;
MDA, malondialdehyde; LDLs, low density lipoproteins; ONOO,
peroxynitrite; NO2, nitrate; NO3, nitrite; NF-jB, nuclear factor kappa
B; IjB, inhibitor of jB; IKK, IjB kinase; NIK, NF-jB inducing
kinase; MAPK, mitogen-activated protein kinase; JNK, c-jun NH2-
terminal kinase; ERK, extracellular signal regulated kinase; MKK,
MAPK kinase kinase; ROS, reactive oxygen species; NO, nitric oxide;
iNOS, inducible nitric oxide synthase; COX-2, cyclooxygenase-2; RS,
reactive species; NAC, N-acetyl cysteine
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propagating process that will proceed until a substrate is
consumed or termination occurs.
There are broad outcomes to lipid peroxidation, structural
damage to membranes and generation of bioactive secondary
products fragmentation of lipid hydroperoxides, in addition to
producing abnormal fatty acid esters, also liberates a number
of diﬀusible products, some of which are potent electrophiles
[3]. The most abundant diﬀusible products of lipid peroxida-
tion are chemically reactive aldehydes, such as malondialde-
hyde (MDA), acrolein, 4-hydroxynonenal (HNE) from the x-6
fatty acyl groups, and 4-hydroxyhexenal (HHE) from the x-3
fatty acyl groups [1].
Reactive aldehydes from lipid peroxidation form adducts
with a number of cellular nucleophiles, including protein, nu-
cleic acids, and some lipids. HNE, especially, is a diﬀusible
product of lipid peroxidation that has been suggested to be a
key mediator of oxidative stress-induced cell death [4]. In
vascular smooth muscle cells, lipid peroxidation products, such
as oxidized low density lipoproteins (LDLs) or bioactive HNE
promote apoptotic cell death through nuclear factor kappa B
(NF-jB) activation [5]. However, some data from previous
studies on reactive aldehydes are conﬂicting with regard to
NF-jB activation [6–8]. Moreover, the mechanism by which
HHE induces endothelial cell dysfunction through the regu-
lation of NF-jB activation has not yet been well deﬁned.
NF-jB has been shown to play a critical role in regulating
the expression of large numbers of genes, including cytokines,
chemokines and other mediators involved in inﬂammatory
responses. NF-jB is a dimeric transcription factor that is
composed of p50 (NF-jB1) and p65 (RelA) subunits [9]. In
cells, NF-jB is retained in the cytoplasm but enters the nucleus
in response to various stimuli including peroxynitrite
(ONOO), nitrate (NO2) and nitrite (NO3) [10]. Activation of
NF-jB is controlled by an inhibitory subunit, inhibitor of jB
(IjB), which retains NF-jB in the cytoplasm. The activation of
NF-jB requires sequential phosphorylation, ubiquitination,
and degradation of IjB, as well as the consequent exposure of
a nuclear localization signal on the NF-jB molecule [9].
Multiple kinases have been shown to phosphorylate IjB at
speciﬁc amino-terminal serine residues [11,12]. The most
studied kinases are IjB kinase, IKKa (or IKK-1) and IKKb
(or IKK-2) [13]. Strong evidence also supports the fact that
IKKa and IKKb are themselves phosphorylated and activatedblished by Elsevier B.V. All rights reserved.
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stream kinase, NF-jB inducing kinase (NIK), was recently
identiﬁed [14]. Phosphorylation of IjB by the IKK pathway
eventually will lead to the nuclear translocation of NF-jB,
which, in turn, will activate the expression of target genes in
the nucleus [15].
Accumulated HNE caused by lipid peroxidation can induce
activation and phosphorylation of extracellular signal regu-
lated kinase (ERK) and p38 mitogen-activated protein kinases
(MAPK) [16]. Two of the MAPKs, ERK and p38 MAPK,
contribute to induction NF-jB activity in response to an array
of extracellular stimuli [12]. Therefore, it would be interesting
to know about the regulation of MAPKs during lipid peroxi-
dation, as lipid peroxidation processes are known to enhance
phosphorylation of MAPKs [17,18]. From these reports, it is
possible that the activation and phosphorylation of ERK and
the p38 MAPK pathway are required for HHE-induced NF-
jB activation via an NF-jB translocation. Thus, in the present
study, we investigated the NF-jB activation mechanism elic-
ited by HHE induction that led to pro-inﬂammatory processes
following NF-jB translocation and its signaling pathways.2. Materials and methods
2.1. Cell line and culture conditions
YPEN-1, rat prostate endothelial cells, was obtained by ATCC
(American type culture collection, USA). The cells were grown in
DMEM (Dulbecco’s Modiﬁed Eagle’s Medium Media, Nissui, Tokyo,
Japan) containing 2 mM L-glutamine, 100 mg/ml streptomycin, 2.5
mg/l amphotericin B and 5% heat-inactivated fetal bovine serum
(FBS). Cells were maintained at 37 C in a humidiﬁed atmosphere
containing 5% CO2/95% air. Cells were discarded after 3 months at
which time new cells were obtained from frozen stock. Cells at expo-
nential phase were used for all experiments and cell viability (>90%)
was assessed by trypan blue exclusion.
2.2. HHE treatments
Commercial HHE (purity >98%; C. NO. 32060), was obtained from
Cayman Chemical Inc. Working solutions of HHE (the ﬁnal concen-
tration never exceeded the 0.1% level of ethanol) were made in PBS
immediately before use. For all experiments, cells were plated in 100
mm culture dishes and cultures at 70–80% of conﬂuences were used for
the chemical exposures. After a 24 h attachment period, media were
replaced with serum free media and cells were treated with 30 lM
HHE after pre-incubated for 30 min with various inhibitors (ERK
inhibitor, PD98059 and p38 MAPK inhibitor, SB203580). After 0–3 h,
cells were harvested with ice-cold PBS. Cell lysates were used for the
Western blot analysis.
2.3. Analysis of proteins by Western blot
Western blotting was carried out as described previously [19]. The
cells were harvested, washed twice with ice-cold phosphate buﬀered
saline (PBS), and lysed in a TNN buﬀer (50 mM Tris–HCl, pH 8.0),
120 mM sodium chloride, and 0.5% Nonidet P-40) that was supple-
mented with protease and phosphatase inhibitors (1 lg/ml leupeptin, 1
lg/ml pepstatin, 1 lg/ml aprotinin, 1 mM phenylmethylsulfonyl ﬂuo-
ride, 0.1 mM sodium orthovanadate, and 50 mM sodium ﬂuoride), for
1 h on ice, vortexing every 5 min. Lysates were centrifuged at 9000 g
for 30 min to remove insoluble material. The protein concentration
was determined by the Lowry’s method using bovine serum albumin
(BSA) as a standard. Equal amounts of protein were separated on 10–
12% SDS–PAGE gels. The gels were subsequently transferred onto a
polyvinylidene diﬂuoride membrane (Millipore Corporation, Bedford,
MA, USA) by electroblotting for 2 h at 60–75 V. Monoclonal anti-
bodies to p-ERK, p-p38, p-JNK, and p-IjB, and polyclonal antibodies
to NF-jB (p65), IjB and p-NIK were purchased from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA, USA). Polyclonal antibody to p-
IKKa/IKKb was purchased from Cell Signaling Inc. (Santa Cruz, CA,
USA). The membranes were blocked in a 5% non-fat milk solution inTBS with 0.5% Tween 20 and incubated with primary antibodies as
indicated. Monoclonal sheep anti-mouse IgG, or donkey anti-rabbit
IgG horseradish peroxidase-conjugated secondary antibodies were
used at a ratio of 1:1000. Proteins were assayed by an enhanced
chemiluminescence (ECL) reagent using a commercial kit (Amersham
Bioscience, Bucks, UK).
2.4. Measurement of intracellular ROS levels
The cells were inoculated at a density of 3 104 cells/well in Costar 48
well plate, were allowed to adhere overnight and then cells were incu-
bated in serum free DMEM with HHE and 10 lM 20,70-dichloroﬂuo-
rescein diacetate (DCF-DA, Molecular Probes, USA) at 37 C. The
change in ﬂuorescence was measured at an excitation wavelength of 485
nm and emission wavelength of 530 nm by Microplate Reader FL500
(Bio-Tek Instruments, Winooski, VT, USA). A ﬂuorometric assay was
performed to determine the relative levels of ROS, such as superoxide
radical, hydroxyl radical, and hydrogen peroxide [20]. This assay
measures the oxidative conversion of stable, non-ﬂuorescent DCF-DA
to the highly ﬂuorescent dichloroﬂuorescein (DCF) in the presence of
esterases and reactive species (RS) [21]. This probe has been used ex-
tensively for quantiﬁcation of ROS and lipid hydroperoxides after
careful examinations for potential pitfalls in the assay conditions [22].
2.5. Electrophoretic mobility shift assay
The electrophoretic mobility shift assay (EMSA) method was used
to characterize the binding activities of NF-jB in nuclear extracts [23].
NF-jB oligonucleotide was 50-GAGAGGCAAGGGGATTCCCTT-
AGTTAGGA-30. Protein-DNA binding mixture containing 20 lg of
nuclear protein extract was incubated for 20 min at 4 C in binding
medium containing 5% glycerol, 1 mM MgCl2, 50 mM NaCl, 0.5 mM
EDTA, 2 mM DTT, 1% NP-40, 10 mM Tris (pH 7.5), and 1 lg of
poly(dI-dC)  poly(dI-dC). Radiolabeled transcription factor consensus
oligonucleotide (20 000 cpm of 32P) was added and the complete
mixture was incubated for additional 20 min at room temperature.
DNA-binding complexes were resolved by 7% native polyacrylamide
gel electrophoresis with 0.5TBE (50 mM Tris, 45 mM boric acid,
and 0.5 mM EDTA) for 90 min at 200 V. The gel was dried and
complexes were established with excess unlabeled oligonucleotide.
2.6. Preparation of cytosolic and nuclear extracts
Treated cells were washed, and then scraped into 1.0 ml of ice-cold
PBS, and pellet at 3000 rpm at 4 C for 5 min. The pellets were sus-
pended in 10 mM Tris (pH 8.0), with 1.5 mM MgCl2, 1 mM DTT,
0.1% NP-40, and protease inhibitors, incubated on ice for 15 min.
Nuclei were separated from cytosol by centrifugation at 12 000 rpm at
4 C for 15 min. The supernatants (cytosolic fraction) were removed
and the pellets were suspended in 10 mM Tris (pH 8.0), with 50 mM
KCl, 100 mM NaCl, and protease inhibitors, incubated on ice for 30
min, then were centrifuged at 12 000 rpm at 4 C for 30 min.
2.7. Analysis of the intracellular ONOO levels by confocal laser
microscopy
The amount of ONOO generated was estimated by assaying the
formation of ﬂuorescent rhodamine-1, 2, 3 from the oxidation of non-
ﬂuorescent DHR according to the modiﬁed method of McBride et al.
[24]. Brieﬂy, cells grown to subconﬂuence on glass coverslips were
incubated with various agents for 30 min prior to treatment with HHE.
Following stimulation for 3 h, cells were washed with PBS, incubated
with 10 lM dihydrorhodamine 123 (DHR123) for an additional 30
min, and mounted in the microscope stage. Fluorescence images were
recorded using a Zeiss LSM 510 laser scanning confocal microscope
with excitation at 488 nm and long-pass detection at 530 nm.
2.8. Measurement of transfection and luciferase reporter assay for
NF-jB activity
NF-jB activity was examined using a luciferase plasmid DNA,
pTAL-NF-jB that contains a speciﬁc binding sequence for NF-jB
(BD Biosciences Clontech, CA, USA) [25]. Transfection was carried
out using FuGENE 6 Reagent (Roche, Indianapolis, IN). Brieﬂy,
5 104 cells per each well were seeded in 24-well plates. When cultured
cells reached about 50% conﬂuence, cells were treated with 0.2 lg
DNA/0.5 ll FuGENE 6 complexes in a total volume of normal media
(5% serum contained) with 500 ll for 42 h. Subsequently, 10 lM of
HHE was treated after the plate was changed with serum-free media,
and treatments of PD205380 and SB203580 were performed 10 min
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PBS and added with Steady-Glo Luciferase Assay System (Promega,
Madison, WI, USA) to the plate. Luciferase activity was measured by
a luminometer (GENious, TECAN, Salzburg, Austria). Raw luciferase
activities were normalized by protein concentration per each well.
2.9. Statistical analysis
The results were presented as means S.E. of three independent
triplicate measurements. Statistical signiﬁcance of diﬀerence between
untreated control and treated groups was determined using one-way
analysis of variance (post-hoc test).Fig. 2. Induction of ONOO generation by HHE. Intracellular
ONOO levels were analyzed with confocal laser microscopy. (A)
control; (B) 30 lM HHE; (C) induction of ONOO generation by
HHE. The cells were incubated in serum free media with the concen-
3. Results
3.1. Induction of ROS and ONOO generation by HHE
One of the products of nitrogen-derived free radicals,
ONOO, is formed by the reaction of two ubiquitous free
radical species: superoxide (O2 ) and nitric oxide (NO) [21]. To
verify the possible involvement of ONOO generation in the
HHE-induced apoptosis of endothelial cells, we measured in-
tracellular ROS and ONOO levels. Cells were treated in
kinetic experiments using various incubation times and doses
(0–30 lM) of HHE. The time course for intracellular ROS
generation was measured by a DCF-DA method. HHE-in-
duced ROS generation was dependent upon concentrations
(Fig. 1). ONOO levels in HHE exposed cells increased as
shown in Fig. 2. At an HHE concentration of 20 lM, the
ONOO level increased signiﬁcantly compared to the un-
treated controls. As shown in Fig. 2B, ONOO levels were
increased in HHE treated cell as compared to untreated con-
trol (see the arrow).
3.2. NF-jB activation by HHE
As shown in Fig. 3, HHE strongly induced NF-jB activa-




























Fig. 1. ROS generation by HHE. Dose-dependent manner of intra-
cellular ROS generation by HHE. The cells were incubated in serum
free media in order to avoid the HHE binding aﬃnity of albumin with
the concentrations of HHE indicated. DCF-DA method was used to
determine the intracellular ROS generation. The results are presented
as meansS.E. of three independent triplicate measurements. Statis-
tical signiﬁcance: *P < 0:05 vs. untreated control.
trations of HHE indicated for 24 h. ONOO levels were measured by
monitoring the oxidation of DHR 123 in equal amounts of cell ho-
mogenates. The results are presented as means S.E. of three inde-
pendent triplicate measurements. Statistical signiﬁcance: *P < 0:05 vs.
untreated control.NF-jB activity was detectable within 1 h, continued to 2 h,
and declined after 3 h of 30 lM HHE stimulation. We ex-
amined the disappearance of IjBa in cytoplasm at the same
time and found that the nuclear DNA-binding activity of the
transcription factor was enhanced strongly by HHE (Fig. 4).
The active forms of NF-jB are heterodimers most often
composed of p50 and p65. Under normal conditions, this form
exists in cytosol in an inactive complex form by the inhibitory
subunit IjB. Because nuclear translocation is a key step for
NF-jB to exert its transcriptional activity [9], the status of the
complex is crucial. Once activated, the transcription of speciﬁc
sets of target genes can mediate a plethora of functions. The
upregulated NF-jB activity we observed in the current ex-
perimentations is widespread biological phenomena found in
aged animals [26,27] and is a critical transcription factor re-
sponsible for the pathogenesis of many disorders, including
inﬂammatory diseases [28].
3.3. NIK–IKKa=b dependent IjBa phosphorylation induced by
HHE
NF-jB is normally present in the cytoplasm in an inactive
state and is bound to members of the IjB inhibitor protein
Fig. 4. Data for gel shift assay on induction of NF-jB binding activity
by HHE. The cells were incubated in serum free media with HHE for
the indicated times. Nuclear fractions were incubated with 32P-end
labeled probe containing a binding site for NF-jB (A). Gel shift assays
with NF-jB probes were performed as described under Section 2.
Quantiﬁcation of the DNA binding activity of NF-jB was performed
by densitometric analysis (B). Statistical signiﬁcance: *P < 0:05 vs.
untreated control. BL, negative control without nuclear extract; Cold,
speciﬁc competition with unlabeled NF-jB oligonucleotide.
Fig. 3. NF-jB translocation and activation through IjB degradation
by HHE. The cells were incubated in serum free media in order to
avoid HHE binding aﬃnity of albumin with 30 lM HHE for 0–4 h.
The levels of p65 and IjBa protein in nuclear extracts (30 lg/lane) and
cytosolic extracts (40 lg/lane) were analyzed by Western blot. The
results are representatives of three independent experiments.
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achieve disruption of this complex, is based on speciﬁc phos-
phorylation of NIK and IKK by HHE stimuli (Fig. 5). We
examined phosphorylation of NIK and IKK by Western blot
analysis using anti-phospho-NIK and IKK. The increased
phospho-NIK and IjBa were detectable within 1 h and con-
tinued to 3 h following 30 lM of HHE (Fig. 5).
Recently, IjBa kinase IKKa and IKKb have been shown to
phosphorylate IjB at speciﬁc amino-terminal serine residues
[12]. There is strong evidence that IKKa and IKKb are phos-
phorylated and activated by upstream kinase NIK [9]. Our re-
sults indicate that HHE may activate NF-jB via activation of
NIK–IKKa=b-dependent IjBa phosphorylation and degrada-
tion, which, in turn, leads to NF-jB nuclear translocation.
3.4. Activation of MAP kinase by HHE
Intracellular oxidative-stress stimuli can activate both NF-
jB and MAP kinase modules [29]. We examined the possibility
that phosphorylation of ERK and p38 MAPK is also involved
in HHE-induced NF-jB activation (Fig. 6). We measured
protein levels by Western blot analysis using anti-active ERK
antibody that recognizes dually phosphorylated (tyrosine andFig. 5. Induction of the NIK and IKK activation by HHE. The cells
were incubated in serum free media with 30 lM HHE for 0–3 h. The
phosphorylated IjBa protein in cytosolic extracts was analyzed by
Western blot with the phospho-IjBa antibody. The amount of phos-
phorylated proteins (IKKa=b and NIK) in whole cell was determined
by Western blot analysis. The data presented are representatives of at
least three separate experiments.
Fig. 6. Eﬀects of HHE on the ERK, p38 MAPK, and JNK phos-
phorylation. The cells were incubated in serum free media with 30 lM
HHE for 0–2 h. Equal amount of phosphorylated proteins determined
by Western blot analysis. The data presented are representatives of at
least three separate experiments.
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dicated that both ERK1 and ERK2 are markedly induced in
the 30 lMHHE-treated cells; activated phospho-ERK1/ERK2
were detectable between 30 min and 2 h. In addition, we ex-
amined phosphorylation of p38 MAPK in YPEN cells treated
with 30 lM HHE for various times. The highest level of p38
MAPK phosphorylation was observed between 30 min and
3 h. Our results also showed that the c-jun NH2-terminal ki-
nase (JNK) activity is not related to HHE induction.
Because nuclear translocation of NF-jB is a key step in
stress induced-NF-jB activation and the activation of MAPK
kinase kinase (MKK) 3/6-p38a=b MAPK pathway is required
for HHE-induced NF-jB-dependent transcription, we inves-
tigated whether MKK3/6-p38a=b MAP kinase pathway
mediates HHE-induced NF-jB activation via induction of
NF-jB nuclear translocation [13]. Our results indicate that
HHE eﬀectively activates ERK and p38 MAPK in addition to
NF-jB (Fig. 6).
3.5. Inhibitory eﬀect of PD98059 and SB203580 on NF-jB
translocation and activation
As shown in Fig. 7, the ERK and p38 MAPK inhibitors
block translocation and activation of NF-jB by HHE. NIK isFig. 7. Suppression of p65 translocation and IjB degradation by SB203580 a
pretreatment for 30 min with SB203580 (10 lM) or PD98059. The levels of p6
extracts (40 lg/lane) were analyzed by Western blot. The data presented are re
p65 and IjBa expression was performed by densitometric analysis. Statistic
HHE.a member of the MAP kinase kinase kinase family that was
ﬁrst identiﬁed as a component of the tumor necrosis factor
receptor 1 (TNF-a1)-induced NF-jB activation pathway [30].
Thus, NF-jB translocation pathway involves activation of
NIK–IKKa=b, ERK and p38 MAPK. Our results clearly
showed evidence that HHE activates NF-jB via NIK/IKK,
p38 MAPK, and ERK dependent signaling pathways (Fig. 8).4. Discussion
Lipid peroxidation and its associated reactive products,
HHE and HNE, are known to cause age-related redox dis-
turbances and various degenerative processes, including vas-
cular dysfunction [31,32]. Age-related endothelial cell
deteriorations due to oxidative stress are intricately involved in
vascular dysfunctions. Among lipid aldehydes, HHE has
strong deleterious eﬀects because of its reactivity. However, to
date, the molecular mechanism by which HHE acts on endo-
thelial cell function has not been fully explored in regard to the
intracellular signaling pathway.
New information generated from this current study on the
HHE action owes to the reactive aldehydes’ characteristic longnd PD98059. The cells were incubated with HHE (30 lM) for 1 h after
5 (A) and IjBa (B) protein in nuclear extracts (30 lg/lane) and cytosolic
presentatives of at least three separate experiments. Quantitation of the
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Fig. 8. Inhibitory eﬀect of SB203580 and PD98059 on the luciferase
activity of NF-jB. Cells were grown in 80–90% conﬂuences after
transfecting a reporter plasmid containing pTAL-NF-jB. The cells
were co-treated with 10 lM HHE and PD98059 (10 lM) and
SB203580 (10 lM) for 6 h. CON; untransfected cells, T-CON; trans-
fected and untreated cells, HHE; transfected cells with HHE (10 lM),
HHE+SB; transfected cell with HHE (10 lM) and SB203580 (10 lM),
HHE+PD; transfected cells with HHE (10 lM) and PD98059 (10
lM). RLU; reactive light units. Statistical signiﬁcance: *P < 0:05 vs.
untreated control; #P < 0:05 vs. 10 lM HHE.
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brane, which is in contrast to free radicals and other RS [33].
Therefore, reactive, non-charged HHE is expected to easily
migrate through the cytosol from the site of production in the
endothelial membranes, eliciting the diverse HHE’s action on
the cellular functions, including the regulation of gene tran-
scription. In human venous plasma, normal HNE levels were
estimated between 0.3 and 1 lM [34]. However, under path-
ological conditions, concentrations of HNE can be markedly
enhanced, accumulated in cellular membranes at concentra-
tions up to 1 mM in response to oxidative insult [1,35]. Thus,
we tried to induce the NF-jB activation with 30 lM HHE in
endothelial cells.
It has been reported that in vascular smooth muscle cells,
lipid peroxidation products, such as oxidized LDLs or bioac-
tive HNE, promote apoptotic cell death through NF-jB acti-
vation [5]. However, some of the data from previous studies
are conﬂicting with regard to the precise mode of NF-jB ac-
tivation [36,37]. For HHE, although HHE-induced NF-jB
activation might be elicited by oxidative stress [3], the mech-
anism by which it regulates endothelial cell dysfunction
through the regulation of NF-jB activation is not well deﬁned.
In our study, evidence indicated that HHE exposure in-
creased oxidative stress in endothelial cells. Among many
transcription factors involved in the intracellular signaling
pathway, NF-jB is known to be exquisitely sensitive to cellular
oxidative status. Thus, the redox-sensitive transcription factor,
NF-jB, could play a crucial role in modulating the expression
of a variety of genes involved in inﬂammatory responses, cell
adhesion, cell cycle, survival and apoptosis in multiple tissues
[38–40]. Among the many well-documented examples are the
dysregulation of NF-jB activation in inﬂammatory and vas-
cular diseases [41,42] through the induction of inducible nitric
oxide synthase (iNOS), cyclooxygenase-2 (COX-2) [26,43].Moreover, vascular changes in structure and function due to
altered ECs are intricately inﬂuenced by the redox-sensitive
NF-jB activation of the pro-inﬂammatory response. We
hypothesized previously that inﬂammation and related pro-
inﬂammatory processes are major underlying causes of aging-
related chronic disease processes [43]. Based on the essential
involvement of NF-jB in inﬂammatory responses, we propose
that HHE induces potent inﬂammatory responses through the
activation of NF-jB process.
The key step involved in the NF-jB regulation is the
translocation of activated NF-jB from the cytoplasm to the
nucleus. Cytoplasmic retention of the inactive IjB/NF-jB
complex is thought to be due to the masking of the dual nu-
clear localization signals located on NF-jB by IjB [44]. On the
basis of this recent revelation, we investigated the role of the
NIK–IKK pathway in HHE-induced NF-jB activation. Our
result clearly demonstrated that HHE activates NF-jB via
activation of NIK–IKKa=b-dependent IjBa phosphorylation
and degradation, leading to NF-jB nuclear translocation.
Recent studies reported the involvement of HNE in stress-
mediated signaling pathway [45]. Several studies showed that
JNK activation is critical for HNE-mediated apoptosis [16].
For instance, Tamagno et al. [46] revealed that HNE mediates
amyloid b-induced neuronal apoptosis by the activation of
JNK and p38 MAPK. In the present study, HHE activated
p38 MAPK and ERK, which led to NF-jB activation. One
possible action of p38 MAPK and ERK during NF-jB acti-
vation is the IKK phosphorylation. The other mechanism by
which HHE-induced NF-jB activation is brought about is
directly through p38 MAPK activation. The transactivation of
NF-jB by phosphorylation and subsequent interaction with
the co-activator protein CBP (CREB-binding protein) is
shown to lead to both acute and chronic inﬂammatory re-
sponses [47]. In our study, we observed no eﬀect of HHE on
JNK activity, indicating that JNK may not be involved in
HHE-induced NF-jB activation.
It has been suggested that NF-jB activation may be medi-
ated by two distinct signaling pathways. First, the NF-jB
translocation dependent pathway involves NIK–IKKa=b-
dependent IjBa phosphorylation and degradation [45]. Sec-
ond, phosphorylation of ERK and p38 MAPK leads to NF-jB
translocation [48]. Although the eﬀect of HNE on NF-jB ac-
tivation was well studied, the HHE’s modulation of NF-jB
activation through the IKK/NIK pathway between the p38
sub-group of MAP kinase has not been reported.
In the present study, a speciﬁc inhibitor of MEK, PD98059
(an upstream activator of EERK1 and ERK2), or a speciﬁc
inhibitor of p38, SB203580, suppressed the HHE-induced NF-
jB activation. Thus, decreased NF-jB activity by these speciﬁc
inhibitors strongly indicates the involvement of ERK and p38
MAPK in the HHE-induced NF-jB activation. The present
study shows for the ﬁrst time that HHE associated activation
of ERK and p38 MAPK signaling pathways in NF-jB
transactivation via IKK/NIK pathway in endothelial cells. In
our previous study [49], N-acetyl cysteine (NAC), ROS in-
hibitor, and penicillamine, ONOO scavenger, blocked
RS-mediated endothelial apoptosis induced by HHE and
suppressed HHE-induced ROS and ONOO levels. These and
current data together strongly indicate the implication of RS in
HHE-induced NF-jB activation via MAPK.
Recently, a study showed that the involvement of ERK,
JNK and p38 MAPK in HNE mediated actin stress ﬁber
J.H. Je et al. / FEBS Letters 566 (2004) 183–189 189formation and barrier function in lung endothelial cells [50].
Our present results strongly indicate that HHE not only in-
creased phosphorylation of ERK and p38 MAPK, but also led
to NF-jB translocation and activation via NIK/IKK pathway.
This activation and phosphorylation of ERK and the p38
MAPK pathways are required for HHE-induced NF-jB acti-
vation and translocation. This interaction may be a cross-talk
site between the NF-jB signaling pathways with MAPK-
related other signaling pathways. Our data provide new in-
sights into the molecular events of HHE-induced endothelial
cells dysfunction and the insidious vascular inﬂammatory
process that is cornerstones in the development of most major
chronic, age-related diseases.
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